RRF plays a pivotal role in bacterial translation by facilitating the recycling of ribosomes after termination of protein synthesis. This process involves the disassembly of the post-termination complex into smaller ribosomal subunits, enabling them to re-initiate translation on the same or different mRNAs. Domain II of RRF is particularly important for this function, as it works in concert with elongation factor G (EF-G) to disassemble the post-termination complex .
In Escherichia coli, RRF depletion leads to the accumulation of post-termination complexes, which can block elongating ribosomes and affect gene expression . In Streptomyces coelicolor, increased expression of RRF enhances protein synthesis, contributing to the overproduction of antibiotics . These studies highlight the importance of RRF in optimizing bacterial translation efficiency.
While specific research on Recombinant Bordetella bronchiseptica Ribosome-recycling factor is scarce, recombinant RRF proteins could potentially be used to enhance protein synthesis in biotechnological applications. For instance, increasing RRF levels might improve the production of valuable proteins or vaccines in bacterial systems.
Bordetella bronchiseptica is a pathogen causing respiratory diseases in animals, including swine . Understanding its genetic and molecular mechanisms is crucial for developing effective treatments. The use of bacteriophages, like Bor-BRP-1, has shown therapeutic potential against B. bronchiseptica infections by modulating inflammatory responses .
Cloning and Expression of B. bronchiseptica RRF: Investigate the cloning and recombinant expression of RRF from B. bronchiseptica to study its role in protein synthesis.
Biotechnological Applications: Explore the use of recombinant RRF to improve protein production in biotechnological systems.
Pathogenicity Studies: Investigate how RRF affects the pathogenicity and virulence of B. bronchiseptica.
KEGG: bbr:BB2608
STRING: 257310.BB2608
Ribosome-recycling factor (RRF), encoded by the frr gene, is essential for bacterial survival as it mediates the dissociation of ribosomes from mRNA after translation termination. This process is critical for "recycling" ribosomes for subsequent rounds of protein synthesis. Studies in Escherichia coli have established that frr is an essential gene, as bacterial strains with disrupted frr cannot sustain growth without complementation . In the absence of proper RRF function, post-termination 70S ribosomal complexes accumulate in 3′-UTRs, and elongating ribosomes become blocked by non-recycled ribosomes at stop codons, severely compromising protein synthesis .
For Bordetella bronchiseptica, a respiratory pathogen in various animals, the ribosome-recycling factor would play a similarly critical role in maintaining protein synthesis efficiency. Understanding its function is particularly relevant given B. bronchiseptica's complex lifestyle as both a persistent colonizer and an acute pathogen.
While the search results don't provide specific sequence or structural comparisons of B. bronchiseptica frr with other bacterial species, we can infer from comparative genomics principles that:
The frr gene is likely highly conserved across bacterial species due to its essential function
Any species-specific variations would primarily occur in non-catalytic regions
B. bronchiseptica, as a member of the Bordetella genus which includes the human pathogen B. pertussis, may have specific adaptations in its translation machinery related to its host interaction strategies
Researchers should conduct sequence alignment analyses to identify B. bronchiseptica-specific features of the frr gene and protein that might reflect adaptation to its ecological niche as a respiratory pathogen.
Based on ribosome profiling studies in E. coli, frr depletion has multiple downstream effects on bacterial physiology:
Accumulation of ribosomes in 3′-UTRs
Blockage of elongating ribosomes at stop codons
Changes in gene expression profiles, particularly affecting ribosome rescue factors
Altered activity of rescue factors including tmRNA and ArfA
The effects of frr depletion specifically in B. bronchiseptica have not been directly documented in the provided search results, but would likely include similar disruptions to translation termination and ribosome availability, with potentially species-specific consequences related to pathogenesis.
Based on successful approaches with other B. bronchiseptica proteins, the following expression system considerations are recommended:
While the search results don't specifically address purification challenges for B. bronchiseptica frr, common issues with bacterial ribosomal proteins include:
Maintaining proper folding and stability during purification
Preventing non-specific RNA binding
Optimizing buffer conditions to maintain functionality
Based on successful purification of other B. bronchiseptica recombinant proteins, researchers should consider:
Using SDS-PAGE to confirm protein expression and purity
Employing buffer systems that maintain protein stability
Considering chromatography methods beyond initial affinity purification, such as ion exchange or size exclusion, to achieve high purity
Validation of protein functionality through activity assays specific to ribosome-recycling function
To verify that recombinant B. bronchiseptica frr retains biological activity, researchers can utilize several approaches:
In vitro ribosome dissociation assays: Using purified B. bronchiseptica ribosomes or heterologous systems to measure the ability of recombinant frr to dissociate post-termination ribosomal complexes
Complementation studies: Testing whether recombinant B. bronchiseptica frr can functionally complement frr-deficient E. coli strains (such as the temperature-sensitive MC1061-2 strain described)
Binding assays with ribosomal components: Investigating interactions between recombinant frr and B. bronchiseptica ribosomal components using techniques like surface plasmon resonance or pull-down assays (similar to methods used for studying Bcr4-BscI interactions)
Structural integrity assessment: Using circular dichroism or thermal shift assays to confirm that the recombinant protein has proper folding
The essential nature of frr makes traditional knockout approaches challenging. Based on strategies used in E. coli and approaches for studying other essential genes, researchers can:
Construct conditional mutants: Create a B. bronchiseptica strain carrying both a chromosomal frame-shifted frr and a wild-type frr on a temperature-sensitive plasmid (similar to the E. coli MC1061-2 strain)
Deploy controlled depletion systems: Use inducible promoters to control frr expression levels and monitor phenotypic consequences
Implement CRISPR interference: Use CRISPRi approaches to partially repress frr expression without complete gene deletion
Perform temperature-sensitivity studies: Analyze growth patterns at permissive and non-permissive temperatures with conditional mutants
Monitor plasmid segregation: Under incompatibility pressure, essential genes like frr cannot be deleted as evidenced by inability to segregate plasmids carrying wild-type frr
While direct evidence linking frr to B. bronchiseptica pathogenesis is not provided in the search results, we can infer potential connections based on bacterial physiology principles:
Translation efficiency during host colonization: As B. bronchiseptica adapts to different microenvironments within the host respiratory tract, efficient ribosome recycling would be critical for rapid protein synthesis adaptation
Stress response during infection: Under host-induced stress conditions, efficient translation termination and ribosome recycling may become even more crucial for bacterial survival
Potential interaction with virulence regulation: The translation machinery often interfaces with regulatory networks controlling virulence factor expression, including the type III secretion system components discussed in the search results
Researchers could investigate these connections through:
Transcriptomic analysis of frr expression during different stages of infection
Proteomic studies of translation efficiency under conditions mimicking the host environment
Examining potential interactions between frr and known virulence regulators
Ribosome profiling, a technique that provides genome-wide information on ribosome positions on mRNAs, could yield valuable insights about frr function in B. bronchiseptica, similar to findings in E. coli :
Mapping translation dynamics: Identify ribosome positioning patterns specific to B. bronchiseptica, particularly at termination sites
Consequences of frr depletion: Establish how ribosome distribution changes across the B. bronchiseptica transcriptome when frr levels are reduced, identifying genes most sensitive to ribosome recycling deficiencies
Species-specific termination characteristics: Determine whether B. bronchiseptica exhibits unique patterns of ribosome behavior at stop codons compared to model organisms
Translational coupling effects: Assess whether frr affects expression of operons containing virulence factors, potentially linking translation efficiency to pathogenesis
Stress response integration: Examine how environmental conditions relevant to infection alter the frr-dependent ribosome distribution
The search results don't directly address frr conservation within Bordetella species, but the available genomic data resources for Bordetella would enable comparative analysis. Researchers should:
Extract frr gene sequences from the comprehensive Bordetella genome database mentioned in search result
Perform multiple sequence alignments to identify:
Core conserved regions likely essential for function
Variable regions that might reflect species-specific adaptations
Selection pressures acting on different regions of the gene
Compare evolutionary rates of frr with other translation-related genes and with virulence factors to understand its relative evolutionary constraints
Analyze genomic context conservation of the frr locus across species to identify potential co-evolutionary patterns with functionally related genes
Structural biology approaches would provide insight into the specific characteristics of B. bronchiseptica frr:
Homology modeling: Using solved structures of RRF from other bacteria as templates to predict the B. bronchiseptica frr structure
Comparative structural analysis: Identifying B. bronchiseptica-specific structural features that might influence:
Interaction with ribosomal components
Stability under different environmental conditions
Potential as a drug target with species selectivity
Molecular dynamics simulations: Examining the dynamic behavior of B. bronchiseptica frr under conditions mimicking the host environment
Structure-function correlations: Mapping sequence conservation onto structural models to identify functionally critical regions versus potentially adaptable regions
While frr is not among the B. bronchiseptica proteins specifically evaluated as vaccine candidates in the search results, the methodological approach used for other recombinant proteins can be applied :
Immunogenicity assessment:
Measure antibody titers in mice immunized with recombinant frr
Determine IgG subtype profiles to characterize the type of immune response (Th1 vs. Th2)
Assess stimulation index in lymphocyte proliferation assays
Protection studies:
Challenge immunized animals with virulent B. bronchiseptica
Monitor protection ratio compared to control groups
Evaluate bacterial clearance from respiratory tissues
Immune response characterization:
Cytokine profiling to determine whether frr induces appropriate protective responses
Analysis of both humoral and cell-mediated immunity components
Based on the evaluation framework used for other B. bronchiseptica proteins, a successful candidate would need to demonstrate both strong antibody responses and protection against challenge, ideally with protection ratios exceeding 50% as observed with the outer membrane porin protein (PPP) and lipoprotein (PL) .
To characterize the protein-protein interaction network involving B. bronchiseptica frr, researchers could employ methods similar to those used to study Bcr4 interactions :
Pull-down assays: Using tagged recombinant frr to identify interacting partners from B. bronchiseptica lysates, followed by mass spectrometry identification
Bacterial two-hybrid screening: Systematically testing potential interactions with translation-related factors and regulatory proteins
Co-immunoprecipitation with specific antibodies: Validating interactions in the native context
Crosslinking studies: Capturing transient interactions during the ribosome recycling process
Truncation analysis: Creating deletion variants of frr to map interaction domains, similar to the approach used with Bcr4
These approaches would help establish whether B. bronchiseptica frr has species-specific interaction partners that might represent novel therapeutic targets.
Translation regulation plays a crucial role in bacterial adaptation to changing environments, including stresses encountered during infection. Research approaches to investigate frr's role in this process could include:
Controlled expression studies: Manipulating frr levels and assessing survival under various stress conditions relevant to host colonization:
Oxidative stress
Nutrient limitation
pH fluctuations
Immune effector exposure
Transcriptome-ribosome profiling integration: Comparing transcriptional and translational responses to stress conditions with normal versus reduced frr levels
Infection model comparisons: Assessing whether frr expression/activity varies between acute infection and persistent colonization states of B. bronchiseptica
Regulatory network mapping: Identifying how frr activity interfaces with stress response regulators in B. bronchiseptica
Understanding these connections could reveal why translation efficiency maintenance through proper ribosome recycling might be particularly important during certain stages of B. bronchiseptica's interaction with its host.
Based on experience with other B. bronchiseptica recombinant proteins, researchers should consider:
| Parameter | Optimization Considerations | Troubleshooting Approaches |
|---|---|---|
| Expression temperature | Lower temperatures (16-20°C) often improve solubility | Test multiple induction temperatures if inclusion bodies form |
| Induction timing | Optimal OD600 for IPTG addition | Monitor growth curves to determine optimal induction point |
| IPTG concentration | Typically 0.5-1.0 mM, but lower concentrations may improve solubility | Titrate IPTG concentrations to balance yield and solubility |
| Lysis conditions | Buffer composition affects stability | Test various buffer systems with different pH values and salt concentrations |
| Affinity tag selection | Impact on structure and function | Consider tag removal if activity issues arise |
| When optimizing expression, researchers should implement systematic variation of these parameters while monitoring both yield and functional activity of the purified protein. |
Comprehensive validation of recombinant B. bronchiseptica frr should include:
Biochemical characterization:
Size exclusion chromatography to confirm monomeric state
Circular dichroism to verify secondary structure elements
Thermal shift assays to assess stability
Mass spectrometry for exact mass confirmation
Functional assays:
Ribosome binding capacity
Ribosome-splitting activity measurement
ATP-dependent recycling efficiency with translation factors
Comparative analysis:
Side-by-side comparison with E. coli frr in functional assays
Evaluation of species-specific functional characteristics
This multi-faceted validation approach ensures that the recombinant protein accurately represents the native B. bronchiseptica frr in both structure and function.
Ribosome profiling for B. bronchiseptica would require careful optimization based on approaches developed for E. coli :
Growth conditions: Standardize conditions that are physiologically relevant to B. bronchiseptica lifestyle
Antibiotic treatment: Optimize chloramphenicol or other translation inhibitors for rapid ribosome fixation
Nuclease digestion parameters: Determine optimal conditions for B. bronchiseptica-specific rRNA content and membrane composition
Fractionation protocols: Adjust for B. bronchiseptica-specific ribosome properties
Computational analysis pipeline: Account for B. bronchiseptica genome features:
Multiple operons
Leaderless mRNAs
Species-specific translation initiation sites
Controls for frr depletion studies: Establish rapid and conditional frr depletion systems
Researchers should also consider comparative ribosome profiling between wild-type and frr-depleted conditions at multiple time points to capture the progression of translation defects, similar to the approach used in E. coli studies .